Mass General Cancer Center Grand Rounds

Fall 2024 - Spring 2025 Grand Rounds

Time: Thursdays, 12:00 PM–1:00 PM
Course Director: Colin D. Weekes, MD, PhD
Co-Course Directors: Douglas Micalizzi, MD, PhD; Lecia Sequist, MD, MPH

The Mass General Cancer Center Grand Rounds program has emerged as a premiere oncology conference in Boston. This program provides an opportunity for Mass General professional staff and fellows to learn from national and international leaders and innovators in cancer treatment and research. This year’s theme for the series is Early Detection.

Grand Rounds offers CME credit, and is structured as a 45-minute lecture followed by 15 minutes of discussion and interaction. Please see below to view the weekly topics and presenters.

Outside of Mass General and interested in viewing the Grand Rounds? Click here to access our new Mass General Cancer Center Grand Rounds subscription available to the public.

View past presentations.

---

Spring 2025 Grand Rounds Schedule

January 9, 2025
ASH Update

Michelle Lee, MD
Mass General Cancer Center

Ben Puliafito, MD
Mass General Cancer Center

Jeremy Abramson, MD
Mass General Cancer Center

Richard Newcomb, MD
Mass General Cancer Center

Debbie Jiang, MD
Mass General Cancer Center

Matt Frigault, MD
Mass General Cancer Center

January 16, 2025
Germline Predisposition to Hematopoietic Malignancies

Lucy Godley, MD, PhD
Northwestern

January 23, 2025
Junior Scientist Lecture Series: Comprehensive tumor cell-based liquid biopsy using microfluidic enrichment of leukapheresis products

Avinash Mishra, PhD
Mass General Hospital

January 30, 2025
Military Service as a Risk Factor for Cancer and What We Can Do About It

Moderator:
Kalo Tanev, MD
Mass General Hospital

Panelists:

Drew Moghanaki, MD
UCLA and VA Radiation Oncologist and US Veteran

Allison Jaslow
CEO of Iraq and Afghanistan Veterans of America

Paul Martin
US Army Vietnam Veteran

February 13, 2025
Engineering Imaging Tools to Improve Early Cancer Detection and Prevention

Rebecca Richards-Kortum, PhD
Rice

February 27, 2025
Early Detection of MRD: A Path Towards Curing More Patients with CRC

Aparna Parikh, MD
Mass General Cancer Center

March 6, 2025
Myeloma: Pillars of Progress

Sagar Lonial, MD, FACP
Emory

March 13, 2025
Thinking about Germline Risk in 2024

Moderator:
Leif Ellisen, MD, PhD
Mass General Hospital

Panelists:

David Christiani, MD
HSPH

Susan Domchek, MD
UPenn

Matthew Yurgelun, MD
DFCI

March 20, 2025
How Can AI Help Intercept Cancer?

Moderator:
Rebecca Mishuris, MD
MGB Chief Information Officer

Panelists:

Regina Barzilay, PhD
MIT

Chris Sander, PhD
HMS

Eleni Linos, MD, MPH, DPhil
Stanford University Dermatology and Digital Health

Keyan Salari, MD, PhD
Mass General Hospital

March 27, 2025
Developing Strategies for Cancer Immunoprevention

Shawn Demehri, MD, PhD
Mass General Hospital

April 3, 2025
The Chabner Pioneers in Oncology Lectureship: How Altered Metabolism Influences Cancer Progression

Matthew G. Vander Heiden
MIT

April 10, 2025
Is it Time to Rethink PSA Screening?

Moderator:
Rick Lee, MD
Mass General Hospital

Panelists:

Adam Feldman, MD, MPH
Mass General Hospital

Brandon Mahal, MD
Radiation Oncologist, University of Miami

Michael Barry, MD
Mass General Hospital

April 17, 2025
The Promise of Goal Concordant Care: Can We Deliver?

Timothy M Pawlik, MD, PHD, MPH
Ohio State

May 1, 2025
Presentation by awardees of the MGH American Cancer Society Institutional Research Grants program

Development of a Multicomponent Supportive Care Mobile Application (THRIVE-CAR-T) for Patients Undergoing Chimeric Antigen Receptor T-cell Therapy (CAR-T)
Patrick Connor Johnson, MD
Mass General Cancer Center

Utilizing liquid biopsies for detection of SCLC transformation in EGFR-mutant lung cancer
Catherine Meador, MD, PhD
Mass General Cancer Center

The role of cigarette smoke in hematologic premalignancy and neoplasia
Peter Miller, MD, PhD
Mass General Cancer Center

Targeting Fibroblast Activation in the Development of Esophageal Adenocarcinoma
Uma Sachdeva, MD, PhD
Mass General Hospital

May 15, 2025
Clinical Pathologic Conference: A 39-Year-Old Man with Abdominal Pain, Paresthesia, and a Spinal Mass

Edwin Choy, MD, PhD
Mass General Cancer Center

Frances Hayes, MBBCh
Mass General Hospital

Jad Hussein, MD
Mass General Hospital

Allen Pineda, MD
Mass General Hospital

Ganesh Shankar, MD
Mass General Hospital

Valentina Zanfagnin, MD
Mass General Hospital

May 22, 2025
State of Cancer: The Current State of Cancer Screening

Robert Smith, PhD
American Cancer Society

Fall 2024 Grand Rounds Schedule

September 19, 2024
Why Should Cancer Centers Develop a Focus on Early Detection?

Moderator:
Lecia Sequist, MD, MPH
Mass General Cancer Center

Panelists:
David P. Ryan, MD
Mass General Cancer Center

Douglas Micalizzi, MD, PhD
Mass General Cancer Center

Erica Warner, ScD
Mass General Research Institute

Elsie M. Taveras, MD, MPH
Mass General Brigham

September 26, 2024
Infectious Disease MGH, A Global View on Virally-Mediated Cancer Risk, Cervical Cancer

Ruanne Barnabas, MBChB, MSc, DPhil
Massachusetts General Hospital

October 10, 2024
"How I Live" Documentary Session

Irini Ablanti, DrPH, MPH, MA
Harvard Humanitarian Initiative
Harvard T. H. Chan School of Public Health
Harvard Medical School

October 17, 2024
Clinical Pathologic Conference: A 75-Year-Old Woman with Multiple Myeloma and Altered Mental Status

Jorg Dietrich, MD, PhD
Mass General Cancer Center

Paul G. Richardson, MD
Dana-Farber Cancer Institute

Matthew Frigault, MD
Mass General Cancer Center

Otto Rapalino, MD
Massachusetts General Hospital

Maria Martinez-Lage Alvarez, MD
Massachusetts General Hospital

October 24, 2024
Town Hall: Health Care in 2024

Congressman Jake Auchincloss
Massachusetts 4th District

October 31, 2024
The Grand Challenge of Cancer Disparities

Melissa Davis, PhD
Morehouse School of Medicine

November 7, 2024
Space-Based Research: Predicting and Preventing Accelerated Stem Cell Aging & Cancer Evolution

Catriona Jamieson, MD, PhD
University of California San Diego

November 14, 2024
Multi-Cancer Detection Assays: Hope or Hype?

Moderator:
Lecia Sequist, MD, MPH
Mass General Cancer Center

Panelists:
Tomasz Beer, MD
Exact Sciences

Jennifer Haas, MD
Massachusetts General Hospital

Betsy O’Donnell, MD
Dana-Farber Cancer Institute

November 21, 2024
Cancer Early Detection Hype or Hope? Lessons from the Oesophagus and Beyond

Rebecca Fitzgerald, OBE, MACantab, MD, FMedSci, EMBO
University of Cambridge

December 5, 2024
Early detection of high grade serous endometrial and ovarian cancers. One step ahead.

Lucy Gilbert, MD, MSc, FRCOG
McGill University

December 19, 2024
Lung Cancer Screening as an Opportunity for Community Outreach and Engagement

Moderator:
Efren Flores, MD
Massachusetts General Hospital

Panelists:
Chi-Fu Jeffrey Yang, MD
Massachusetts General Hospital

Rian Hasson, MD, MPH, FACS
Brigham and Women’s Hospital

Michael Gieske, MD
St. Elizabeth Healthcare

Previous Grand Rounds

Spring 2024

January 4, 2024
ASH Update

Classical Heme (Jonathan Carlson, MD, PhD)
Leukemia (Rupa Narayan, MD)
Lymphoma (Jacob Soumerai, MD)
Myeloma (Diana Cirstea, MD)
BMT (Richard Newcomb, MD)
Cell Therapy (Mark Leick, MD)

January 11, 2024
Integrating Clinical and Laboratory Research to Identify Mechanisms of Response and Resistance to Immune Checkpoint Therapy

Padmanee Sharma, MD, PhD
MD Anderson Cancer Center

January 18, 2024
From the Ether Dome to Seldin Plaza: My Path in Renal Cell Carcinoma

Tian Zhang, MD
UT Southwestern Medical Center

January 25, 2024
Can’t Stop, Won’t Stop: The Development of New Therapies, and New Trialists, Toward a Future of Cure

Janice Mehnert, MD
NYU Langone Health

February 1, 2024
From Trailblazers to Leaders: Role of Women As Division Chiefs

S. Gail Eckhardt, MD, FASCO
Baylor College of Medicine

Merry Markham, MD, FACP, FASCP
University of Florida Health

February 8, 2024
Advocacy in Oncology: Connecting What Matters with Our Science and Care

Pamela Kunz, MD
Yale School of Medicine

February 29, 2024
Brain Metastases of Breast Cancer

Patricia Steeg, PhD
National Institutes of Health

March 7, 2024
Gastric Cancer Program: Innovations and Advances

Vivian Strong, MD, FACS
Memorial Sloan Kettering Cancer Center

March 14, 2024
Rethinking Radiation Oncology Using HPV Driven Oropharyngeal Carcinoma as a Model

Nancy Lee, MD, FASTRO
Memorial Sloan Kettering Cancer Center

March 21, 2024
Bridging the GAP While Shattering Ceilings

Rachna Shroff, MD, MS, FASCO
University of Arizona Cancer Center

March 28, 2024
Porphyria: New Therapies and Research

Rebecca Karp, MD
Massachusetts General Hospital

Amy Dickey, MD, MSc
Massachusetts General Hospital

April 4, 2024
DEI as a Competitive Advantage

Clifton David Fuller, MD, PhD
MD Anderson Cancer Center

April 11, 2024
Catch Me If You Can: Resistance to CART Immunotherapy

Marco Ruella, MD
University of Pennsylvania

April 25, 2024
Treating AML in 2024: Individualizing Treatment Approaches with Novel Therapies

Courtney DiNardo, MD, MSCE
MD Anderson Cancer Center

May 2, 2024
ACS-IRG Scholars

Shadi Abdar Esfahani, MD, MPH
Massachusetts General Hospital

Jamie Jacobs, PhD
Massachusetts General Hospital

Julie Miller, MD, PhD
Mass General Cancer Center

Gary X. Wang, MD, PhD
Massachusetts General Hospital

May 9, 2024
Circulating tumor DNA analysis for non-invasive detection of cancers

Max Diehn, MD, PhD
Stanford University

May 16, 2024
State of Cancer: National Efforts to Ensure Health Equity For All Americans

Elizabeth Jaffee, MD
Johns Hopkins Medicine

May 23, 2024
Clinical Pathologic Conference: NEJM Case Records of the MGH: A 59-year-old woman with a breast mass

Bayan Alzumaili, MD; Rebecca Kwait, MD; Daniel Soto, MD; Sahar Shahamatdar, MD, PhD; Janice Thai, MD; Seth Wander, MD, PhD; Lori Wirth, MD
Massachusetts General Hospital

Fall 2023

September 7, 2023
The Chabner Pioneers in Oncology Lectureship – Precision Medicine for Primary and Metastatic Brain Tumors: From Bench to Bedside (and Back to Bench)

Priscilla Brastianos, MD
Mass General Cancer Center

September 21, 2023
Junior Scientist Lectures

Targeted Approaches to Treatment of Pleural Mesothelioma: Are We There Yet?

Ibiayi Dagogo-Jack, MD
Mass General Cancer Center

Gut Bacteria Illuminate a Mechanistic Strategy for Cancer Immunotherapy

Francesca Gazzaniga, PhD
Massachusetts General Hospital

September 28, 2023
Structure and Function of Mammalian SWI/SNF Chromatin Remodeling Complexes in Cancer

Cigall Kadoch, PhD
Dana-Farber Cancer Institute

October 5, 2023
Novel Therapeutics in Gynecologic Cancers

Roisin O’Cearbhaill, MD
Memorial Sloan-Kettering Cancer Center

October 12, 2023
Women in Cancer: Navigating the Glass Ceiling

Lisa Butterfield, PhD
University of California San Francisco

Kornelia Polyak, MD, PhD
Dana-Farber Cancer Institute

Noopur Raje, MD
Mass General Cancer Center

October 26, 2023
Lippard Lecture: Defining and Exploiting Tumor-Host Interactions

Christina Curtis, PhD, MSc
Stanford University

November 9, 2023
Achieving Success as A Square Peg in the Round Hole of Academic Medicine

Jennifer Temel, MD
Mass General Cancer Center

November 30, 2023
Female Participant Engagement in Cancer Research: Sample Programs from the Field to a Pandemic

Lourdes Baezconde-Garbanati, PhD
University of Southern California

December 7, 2023
The Dobbs Decision: Implications for Women’s Health and Cancer Care

Lisa Barroilhet, MD
University of Wisconsin School of Medicine and Public Health

December 14, 2023
Targeted Therapy for Premenopausal Early Breast Cancer: A 100 Year Old Strategy

Sandra Swain, MD
Georgetown University Medical Center